Correlation Between Genelux Common and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Genelux Common and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genelux Common and Processa Pharmaceuticals, you can compare the effects of market volatilities on Genelux Common and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Processa Pharmaceuticals.

Diversification Opportunities for Genelux Common and Processa Pharmaceuticals

-0.25

Correlation Coefficient

Genelux Common  Processa Pharmaceuticals

Very good diversification

The 3 months correlation between Genelux and Processa is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Genelux Common i.e., Genelux Common and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Genelux Common and Processa Pharmaceuticals

Given the investment horizon of 90 days Genelux Common is expected to under-perform the Processa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Genelux Common is 1.86 times less risky than Processa Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Processa Pharmaceuticals is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1,320  in Processa Pharmaceuticals on September 13, 2024 and sell it today you would lose (1,194) from holding Processa Pharmaceuticals or give up 90.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Genelux Common  vs.  Processa Pharmaceuticals

Genelux Common

Risk-Adjusted Performance

4 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common showed solid returns over the last few months and may actually be approaching a breakup point.

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Processa Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Genelux Common and Processa Pharmaceuticals

The main advantage of trading using opposite Genelux Common and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Genelux Common and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.